ATC Index
Comprehensive guide to Amiodarone, a powerful antiarrhythmic drug (ATC C01BD01) used for life-threatening heart rhythm disorders. Learn about its uses, dosage, potential side effects, and safe acquisition.
Browse our catalog for available pharmaceutical products and competitive pricing.
Amiodarone is a potent antiarrhythmic medication used primarily to treat and prevent a variety of severe and often life-threatening heart rhythm disturbances (arrhythmias). It belongs to a unique class of antiarrhythmic drugs that possess properties of all four Vaughan Williams classes, making it highly effective but also associated with a complex side effect profile. Its chemical structure includes iodine, which contributes to some of its characteristic adverse effects, particularly those affecting the thyroid gland. Due to its efficacy in managing refractory arrhythmias, Amiodarone is considered a cornerstone in the pharmacological management of serious cardiac dysrhythmias.
First synthesized in 1961 by the Belgian company Labaz, Amiodarone was initially developed as an antianginal agent. However, its potent antiarrhythmic properties were discovered later, leading to its approval for arrhythmia treatment in Europe in the early 1980s and subsequently by the U.S. Food and Drug Administration (FDA) in 1985. Its introduction revolutionized the treatment of complex arrhythmias, particularly those unresponsive to other therapies. Despite its widespread use, the long half-life and potential for significant organ toxicity necessitate careful patient selection, meticulous monitoring, and a thorough understanding of its pharmacological nuances.
As per the Anatomical Therapeutic Chemical (ATC) classification system, Amiodarone is categorized under C01BD01, within the broader group C01 (Cardiac therapy) and C01B (Antiarrhythmics, class I and III). Specifically, it is a Class III antiarrhythmic drug, meaning its primary action is to prolong the cardiac action potential and refractory period by blocking potassium channels. However, it also exhibits Class I (sodium channel blockade), Class II (beta-adrenergic blockade), and Class IV (calcium channel blockade) properties, distinguishing it from other antiarrhythmics and contributing to its broad spectrum of action against various types of arrhythmias. This multi-channel blocking capability makes Amiodarone exceptionally effective in stabilizing erratic heart rhythms.
The primary mechanism of action of Amiodarone is its ability to block potassium channels in the myocardium, specifically delayed rectifier potassium channels. This blockade leads to a significant prolongation of the repolarization phase of the cardiac action potential and an increase in the effective refractory period in atrial, nodal, and ventricular tissues. By extending the time during which cardiac cells cannot be re-excited, Amiodarone effectively prevents the re-entry circuits that often underlie tachyarrhythmias. This Class III antiarrhythmic activity is crucial for its efficacy in controlling both supraventricular and ventricular arrhythmias, offering a powerful means to restore and maintain normal sinus rhythm.
Beyond its dominant Class III effects, Amiodarone exhibits a complex pharmacological profile by also acting as a Class I, II, and IV antiarrhythmic. It blocks inactivated sodium channels (Class I effect), which slows conduction velocity. It also possesses non-competitive beta-adrenergic receptor blocking properties (Class II effect), which can decrease heart rate and AV nodal conduction. Furthermore, Amiodarone blocks calcium channels (Class IV effect), contributing to its ability to slow AV nodal conduction and reduce myocardial contractility. These multiple actions contribute to its broad antiarrhythmic spectrum, making it effective in a wide range of cardiac dysrhythmias, but also contributing to its potential for diverse systemic side effects.
Amiodarone is a highly effective antiarrhythmic agent primarily indicated for the treatment and prophylaxis of severe, recurrent ventricular arrhythmias that are unresponsive to other antiarrhythmic drugs or in patients for whom other agents are contraindicated or not tolerated. Its broad spectrum of action also makes it valuable in managing various supraventricular arrhythmias, particularly atrial fibrillation and flutter, when rhythm control is desired and other options have failed. It is often reserved for more critical situations due to its potential for significant extracardiac side effects.
The dosage of Amiodarone is highly individualized and depends significantly on the indication, patient response, and tolerance. It is administered via both oral and intravenous routes. Oral administration typically involves a loading phase to achieve therapeutic tissue concentrations quickly, followed by a lower maintenance dose. Intravenous Amiodarone is used for acute management of life-threatening arrhythmias, often starting with a rapid bolus followed by a continuous infusion. Due to its long half-life, it can take several weeks for the full antiarrhythmic effect to manifest with oral dosing, and similarly, adverse effects can persist long after discontinuation.
| Indication | Typical Dose | Frequency | Route |
|---|---|---|---|
| Ventricular Arrhythmias (Oral Loading) | 800-1600 mg/day | Daily (divided into 2-3 doses) | Oral |
| Ventricular Arrhythmias (Oral Maintenance) | 200-400 mg/day | Once daily | Oral |
| Acute Ventricular Arrhythmias (IV Loading) | 150 mg over 10 minutes | Once, followed by infusion | Intravenous |
| Acute Ventricular Arrhythmias (IV Infusion) | 1 mg/min for 6 hours, then 0.5 mg/min | Continuous | Intravenous |
Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition, and require careful titration and monitoring. Never adjust your dose without medical advice.
Amiodarone is known for its wide array of potential side effects, many of which are related to its long half-life and accumulation in various tissues. Due to its iodine content and lipophilicity, it can affect nearly every organ system. Regular monitoring of thyroid function, liver enzymes, and pulmonary function is essential during treatment with Amiodarone.
Amiodarone has a high potential for significant drug interactions due to its extensive metabolism by cytochrome P450 enzymes (particularly CYP3A4 and CYP2C8) and its inhibitory effects on several CYP enzymes (CYP2C9, CYP2D6, CYP3A4) and P-glycoprotein. These interactions can lead to increased levels and enhanced effects of co-administered medications, potentially increasing the risk of adverse reactions or toxicity. It is crucial for healthcare providers to review all concomitant medications when prescribing Amiodarone.
Amiodarone is a powerful medication with specific contraindications and requires careful consideration due to its potential for serious adverse effects. It should not be used in certain patient populations or conditions where the risks outweigh the potential benefits.
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. This article does not provide medical advice, diagnosis, or treatment.
Long-term use of Amiodarone is generally reserved for patients with severe, life-threatening arrhythmias where its benefits outweigh the risks of significant and potentially irreversible side effects. While effective, its prolonged use is associated with a higher incidence of adverse effects affecting the lungs, liver, thyroid, eyes, and skin. Therefore, patients on long-term Amiodarone therapy require regular and comprehensive monitoring, including pulmonary function tests, liver function tests, thyroid function tests, and ophthalmological examinations, to detect and manage potential toxicities early. The decision for long-term use is always made in consultation with a cardiologist.
Yes, Amiodarone can and often should be taken with food. Taking oral Amiodarone with meals is generally recommended as it can help reduce gastrointestinal upset, which is a common side effect. Furthermore, some studies suggest that food, particularly fatty meals, can enhance the absorption of Amiodarone, leading to more consistent drug levels. However, it's important to maintain consistency with how you take it (always with food or always without) to ensure stable drug concentrations. Always follow your doctor's specific instructions regarding administration.
If you miss a dose of Amiodarone, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one, as this can increase the risk of side effects. Due to Amiodarone's very long half-life, missing a single dose is unlikely to have a significant immediate impact on its therapeutic effect. However, consistent dosing is important for maintaining stable drug levels. If you are unsure or frequently miss doses, consult your healthcare provider for advice.
Amiodarone is a prescription-only medication. It cannot be bought over-the-counter and requires a valid prescription from a licensed healthcare professional. You can obtain Amiodarone from licensed pharmacies, either retail pharmacies or hospital pharmacies, once you have a prescription. It is crucial to purchase Amiodarone only through legitimate medical channels to ensure its authenticity, quality, and safety. Avoid buying medications from unregulated online sources or unauthorized vendors, as these products may be counterfeit, contaminated, or incorrectly dosed, posing serious health risks. Always prioritize your safety and consult your doctor or pharmacist.
Chat on WhatsApp